CGTX
Price
$1.74
Change
+$0.09 (+5.45%)
Updated
Nov 28 closing price
Capitalization
146.54M
123 days until earnings call
Intraday BUY SELL Signals
KALV
Price
$14.47
Change
+$0.37 (+2.62%)
Updated
Nov 28 closing price
Capitalization
731.4M
Intraday BUY SELL Signals
Interact to see
Advertisement

CGTX vs KALV

Header iconCGTX vs KALV Comparison
Open Charts CGTX vs KALVBanner chart's image
Cognition Therapeutics
Price$1.74
Change+$0.09 (+5.45%)
Volume$674.77K
Capitalization146.54M
KalVista Pharmaceuticals
Price$14.47
Change+$0.37 (+2.62%)
Volume$719.08K
Capitalization731.4M
CGTX vs KALV Comparison Chart in %
CGTX
Daily Signal:
Gain/Loss:
KALV
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CGTX vs. KALV commentary
Nov 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGTX is a StrongBuy and KALV is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 30, 2025
Stock price -- (CGTX: $1.74 vs. KALV: $14.47)
Brand notoriety: CGTX and KALV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGTX: 45% vs. KALV: 54%
Market capitalization -- CGTX: $146.54M vs. KALV: $731.4M
CGTX [@Biotechnology] is valued at $146.54M. KALV’s [@Biotechnology] market capitalization is $731.4M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.02B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGTX’s FA Score shows that 1 FA rating(s) are green whileKALV’s FA Score has 0 green FA rating(s).

  • CGTX’s FA Score: 1 green, 4 red.
  • KALV’s FA Score: 0 green, 5 red.
According to our system of comparison, CGTX is a better buy in the long-term than KALV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGTX’s TA Score shows that 7 TA indicator(s) are bullish while KALV’s TA Score has 4 bullish TA indicator(s).

  • CGTX’s TA Score: 7 bullish, 2 bearish.
  • KALV’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CGTX is a better buy in the short-term than KALV.

Price Growth

CGTX (@Biotechnology) experienced а +25.18% price change this week, while KALV (@Biotechnology) price change was +10.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.92%. For the same industry, the average monthly price growth was +1.16%, and the average quarterly price growth was +72.91%.

Reported Earning Dates

CGTX is expected to report earnings on Apr 01, 2026.

Industries' Descriptions

@Biotechnology (+6.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KALV($731M) has a higher market cap than CGTX($147M). CGTX YTD gains are higher at: 148.111 vs. KALV (70.838). CGTX has higher annual earnings (EBITDA): -32.73M vs. KALV (-187.27M). KALV has more cash in the bank: 191M vs. CGTX (10.7M). CGTX has less debt than KALV: CGTX (468K) vs KALV (6.14M). KALV has higher revenues than CGTX: KALV (1.43M) vs CGTX (0).
CGTXKALVCGTX / KALV
Capitalization147M731M20%
EBITDA-32.73M-187.27M17%
Gain YTD148.11170.838209%
P/E RatioN/AN/A-
Revenue01.43M-
Total Cash10.7M191M6%
Total Debt468K6.14M8%
FUNDAMENTALS RATINGS
KALV: Fundamental Ratings
KALV
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGTXKALV
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
78%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 10 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
CGTX
Daily Signal:
Gain/Loss:
KALV
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ORZCF1.130.06
+5.25%
Orezone Gold Corp.
SMECF351.940.03
+0.01%
SMC Corp
TTNN0.04N/A
N/A
TITAN NRG
CHEV5.09N/A
N/A
Charging Robotics Inc.
VLOUF18.41-0.59
-3.08%
Vallourec SA

CGTX and

Correlation & Price change

A.I.dvisor tells us that CGTX and LGVN have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CGTX and LGVN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGTX
1D Price
Change %
CGTX100%
+5.45%
LGVN - CGTX
31%
Poorly correlated
+2.50%
KALV - CGTX
29%
Poorly correlated
+2.62%
RGNX - CGTX
29%
Poorly correlated
+0.98%
BRCTF - CGTX
28%
Poorly correlated
N/A
ABCL - CGTX
28%
Poorly correlated
+2.47%
More